Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Transplantation Proceedings
|
October 1, 1994
Application of the EMIT cyclosporine assay to the Technicon Axon System
D F LeGatt, M Chooi, A I Simpson, et al.
Clinical Chemistry
|
January 1, 1997
Effect of assay methodology on pharmacokinetic differences between cyclosporine Neoral and Sandimmune formulations
L J Aspeslet, D F LeGatt, G Murphy, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1984
Rat brain concentrations of 5-hydroxytryptamine following acute and chronic administration of MAO-inhibiting antidepressants
G B Baker, D F LeGatt, R T Coutts, et al.
Proceedings of the Western Pharmacology Society
|
January 1, 1983
A comparison of the effects of chronic administration of tranylcypromine and phenelzine on rat brain levels of the catecholamines and their O-methylated metabolites
J M Baker, G B Baker, R T Coutts, et al.
Journal of Pharmaceutical Sciences
|
November 1, 1978
Effect of diphenhydramine on methaqualone metabolism: an in vitro study
K W Hindmarsh, N W Hamon, D F LeGatt, et al.
Therapeutic Drug Monitoring
|
April 1, 1997
Pharmacodynamic monitoring of mycophenolic acid in rabbit heterotopic heart transplant model
L J Langman, H Nakakura, J A Thliveris, et al.
Clinical Chemistry
|
January 1, 1991
HPLC analysis of flecainide enantiomers in plasma: comparison with fluorescence polarization immunoassay
S Alessi-Severini, D F LeGatt, F M Pasutto, et al.
Progress in Neuro-Psychopharmacology
|
January 1, 1981
Screening for amines of psychiatric interest in urine using gas chromatography with electron-capture detection
R T Coutts, G B Baker, D F LeGatt, et al.
Transplantation Proceedings
|
April 1, 1996
Pharmacodynamic assessment of mycophenolic acid in a canine model
L J Langman, A M Shapiro, J R Lakey, et al.
Therapeutic Drug Monitoring
|
August 12, 1999
Some international approaches to aminoglycoside monitoring in the extended dosing interval era
R G Morris, B C Sallustio, A A Vinks, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Transplantation Proceedings
|
October 1, 1994
Application of the EMIT cyclosporine assay to the Technicon Axon System
D F LeGatt, M Chooi, A I Simpson, et al.
Clinical Chemistry
|
January 1, 1997
Effect of assay methodology on pharmacokinetic differences between cyclosporine Neoral and Sandimmune formulations
L J Aspeslet, D F LeGatt, G Murphy, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1984
Rat brain concentrations of 5-hydroxytryptamine following acute and chronic administration of MAO-inhibiting antidepressants
G B Baker, D F LeGatt, R T Coutts, et al.
Proceedings of the Western Pharmacology Society
|
January 1, 1983
A comparison of the effects of chronic administration of tranylcypromine and phenelzine on rat brain levels of the catecholamines and their O-methylated metabolites
J M Baker, G B Baker, R T Coutts, et al.
Journal of Pharmaceutical Sciences
|
November 1, 1978
Effect of diphenhydramine on methaqualone metabolism: an in vitro study
K W Hindmarsh, N W Hamon, D F LeGatt, et al.
Therapeutic Drug Monitoring
|
April 1, 1997
Pharmacodynamic monitoring of mycophenolic acid in rabbit heterotopic heart transplant model
L J Langman, H Nakakura, J A Thliveris, et al.
Clinical Chemistry
|
January 1, 1991
HPLC analysis of flecainide enantiomers in plasma: comparison with fluorescence polarization immunoassay
S Alessi-Severini, D F LeGatt, F M Pasutto, et al.
Progress in Neuro-Psychopharmacology
|
January 1, 1981
Screening for amines of psychiatric interest in urine using gas chromatography with electron-capture detection
R T Coutts, G B Baker, D F LeGatt, et al.
Transplantation Proceedings
|
April 1, 1996
Pharmacodynamic assessment of mycophenolic acid in a canine model
L J Langman, A M Shapiro, J R Lakey, et al.
Therapeutic Drug Monitoring
|
August 12, 1999
Some international approaches to aminoglycoside monitoring in the extended dosing interval era
R G Morris, B C Sallustio, A A Vinks, et al.
Page
of 5